<DOC>
	<DOC>NCT00000207</DOC>
	<brief_summary>The purpose of this study is to test the efficacy and safety of buprenorphine.</brief_summary>
	<brief_title>Multicenter Clinical Trial of Buprenorphine - 3</brief_title>
	<detailed_description>12 different sites for a total of 736 subjects (60 at Pizarro, 70 at West LA Tx center, 15 in the 1 year extension)</detailed_description>
	<mesh_term>Opioid-Related Disorders</mesh_term>
	<mesh_term>Buprenorphine</mesh_term>
	<criteria>M/F, ages 2150. opiate dependence according to DSMIV criteria. Selfreported use within the last 30 days. Agreeable to conditions of the study and signed informed consent. Psychiatric disorder that requires medication therapy. History of seizures. Pregnant and/or nursing women. Dependence on ETOH or benzodiazepines or other sedativehynotics. Acute hepatitis. Other medical conditions that deem participation to be unsafe.</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>Buprenorphine</keyword>
	<keyword>Opioid</keyword>
</DOC>